Observational study on initiation of dapagliflozin in heart failure with reduced ejection fraction in the United Kingdom - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Real-World Analysis of Dapagliflozin Initiation in Patients with Heart Failure and Reduced Ejection Fraction in the UK

  • By

  • Steven Coombs

  • Angela Tithecott

  • Cristina Thiebaud

  • Parminder Chaggar

  • Diane Barker

  • Prithwish Banerjee

  • Henry Oluwasefunmi Savage

  • Alastair Gray

  • Geraint Jenkins

  • Mohammad Albarjas

  • Liz Hennessy

  • Joanna De Courcy

  • Hannah Wallis

  • Thom Dewar

  • Reece Manuell

  • Sophie Barlow

  • Samuel Adamsson Eryd

  • Jil Billy Mamza

  • Tamsin Morris

  • September 8, 2026

Share

Original Source(s)

Observational study on initiation of dapagliflozin in heart failure with reduced ejection fraction in the United Kingdom

  • by Steven Coombs, Angela Tithecott, Cristina Thiebaud, Parminder Chaggar, Diane Barker, Prithwish Banerjee, Henry Oluwasefunmi Savage, Alastair Gray, Geraint Jenkins, Mohammad Albarjas, Liz Hennessy, Joanna De Courcy, Hannah Wallis, Thom Dewar, Reece Manuell, Sophie Barlow, Samuel Adamsson Eryd, Jil Billy Mamza, Tamsin Morris

  • September 8, 2026

Related Content

When Heart Failure Treatment Isn’t Enough: Signs It’s Time to Refer for Advanced Heart Failure Care

Advanced heart failure does not always present as a single defining event. Referring physicians may instead notice a pattern of worsening symptoms, recurrent hospitalizations or increasing difficulty maintaining a patient’s clinical stability.

  • by

  • August 28, 2026

  • 6 min
Sodium Thiosulfate for Refractory Metabolic Alkalosis From Diuretic Therapy: A Case Series of Six Patients

  • September 1, 2026

Mobile Integrated Health and Post–Hospital Discharge Heart Failure Care